Introduction
============

Spinal metastatic tumor is a common metastatic tumor of many advanced malignant tumors, which is mainly formed by the primary tumor transferring to the spine through blood or lymph metastasis ([@b1-etm-0-0-8310]). Spinal tumors are often characterized by multiple lesions involving multiple segments and accompanied by severe pain, which has a serious impact on the quality of life and health of patients ([@b2-etm-0-0-8310]). In the past, radiotherapy and chemotherapy as well as surgery were mainly used for the treatment of spinal metastases clinically. However, radiotherapy and chemotherapy for patients not only have a long treatment cycle, but also have many adverse reactions. Therefore, with the continuous development of medical technology in recent years, surgery has gradually become the main method for the treatment of spinal metastases. However, surgery still has the problems of large trauma, incomplete resection, and high recurrence rate ([@b3-etm-0-0-8310],[@b4-etm-0-0-8310]). Therefore, it is of great clinical significance to find a treatment method with better efficacy and less adverse effects for patients with spinal metastatic tumors ([@b5-etm-0-0-8310]).

Radiofrequency ablation is a tumor therapy method that has been gradually applied clinically in recent years. It mainly inactivates and damages tumor tissues of patients through friction heat generated by high-frequency current. It has the characteristics of less trauma and fewer complications ([@b6-etm-0-0-8310]). At present, radiofrequency ablation has achieved good efficacy in the treatment of various metastatic tumors such as bone metastasis of breast cancer ([@b7-etm-0-0-8310]), liver metastasis of rectal cancer ([@b8-etm-0-0-8310]), and the combination of surgery. There is also research ([@b9-etm-0-0-8310]) showing that patients with spinal metastases have achieved 89 and 70% local control, respectively, in 3 months and 1 year after percutaneous radiofrequency ablation.

Although some studies have been reported on the application of radiofrequency ablation in spinal metastatic tumors, few studies have been carried out to analyze the effects of radiofrequency ablation and the influencing factors on the prognosis of patients. Therefore, in this study, the effects of radiofrequency ablation assisted with traditional open surgery in spinal metastatic tumors and the influencing factors on the prognosis of patients, were analyzed with a view to provide more basis for clinical treatment of patients with spinal metastatic tumors.

Materials and methods
=====================

### General data

A total of 132 patients with spinal metastases from April 2014 to February 2016 were selected, including 71 male and 61 female patients. Their average age was 57.64±10.29. The patients were divided into research group and control group according to the treatment plan accepted by the patients. Sixty-seven patients with simple surgery were regarded as the control group, and 65 patients with radiofrequency ablation assisted surgery were the research group. Inclusion exclusion criteria were as follows: Inclusion criteria were as follows: Patients diagnosed as spinal metastases by pathological diagnosis, patients who have undergone primary tumor resection, patients with an expected survival period of more than 6 months, and patients with preoperative tolerance to surgery. Exclusion criteria were as follows: Patients with contraindications to surgery, patients with unclear primary focus, patients with severe liver and kidney dysfunction, patients with unclear surgical indications, patients with serious heart and lung diseases, patients who did not cooperate with the study, patients with communication or cognitive impairment. All patients and their families agreed to participate in the experiment and sign an informed consent. The study was approved by the Ethics Committee of Weifang People\'s Hospital (Weifang, China).

### Treatment methods

All patients underwent imaging examination before surgery to determine the location and number of lesions and cones, and the degree of cone deterioration and spinal cord compression were evaluated. The patients in the control group were treated with simple open cone resection. After general anesthesia, the patients were placed in prone position. The pathological cones located before surgery were taken as the center to make a longitudinal incision. The upper and lower cones of the pathological cones were fixed and the muscles beside the cones were separated. First, accessory tumors such as vertebral pedicle or lamina were excised. Then, unilateral laminectomy and decompression were performed. In addition, tumor tissues that compressed spinal cord in spinal canal were excised. In order to better perform bone graft fusion, during the resection of the affected cone, attention should also be paid to the removal of its corresponding upper and lower intervertebral discs. After the resection was completed, bone cement was poured into the resection site. The resection site was filled with bone cement. After the bone cement was solidified, the bone threading needle was pulled out and the operation area was sterilized and flushed. The drainage tube was placed for negative pressure drainage. Finally, the incision was closed. Patients in the research group were assisted with radiofrequency ablation on the basis of patients in the control group. After cone resection, UniBlate monopolar needle electrode (RITA1500X type) was introduced into the pathological cones through vertebral pedicle under X-ray fluoroscopy, and the initial power was set at 150 W. The ablation range was set according to the tumor and the pathological degree. The temperature of the radiofrequency needle was controlled at 80--100°C. The time of single point ablation is 6--12 min. During ablation, the blood loss and changes of vital signs of patients were closely detected. The ablation area was appropriately expanded to 0.5 cm beyond the edge of the lesions. Bone cement was injected after ablation. The method was the same as that of the control group. All patients were treated with cefradine (2 g/12 h) for 3 days after surgery.

### Observation indicators

i\) The time of operation and intraoperative blood loss of patients in the two groups were recorded and compared. ii) Visual analogue pain score (VAS) ([@b10-etm-0-0-8310]) was evaluated before and 6 months after surgery of patients in both groups. iii) The Karnofsky (KPS) ([@b11-etm-0-0-8310]) scores before and 6 months after surgery of patients in the two groups were compared. iv) The Frankel spinal cord injury grading ([@b12-etm-0-0-8310]) before and 6 months after surgery of patients in the two groups were compared. v) The complications of patients in the two groups within 6 months after surgery were recorded and compared. The complications included bone cement leakage, hemorrhage, deep venous thrombosis of lower limbs, and infection. vi) The patients were followed up for 36 months and the survival rates of the two groups were analyzed. vii) Cox regression model was used to analyze the factors affecting the prognosis of patients.

### Statistical methods

In this study, the experimental data were statistically analyzed by SPSS 18.0 software. The counting data adopted Chi-square test, and the measurement data adopted mean ± standard deviation. The comparison between the two groups adopted t test. The experimental images were drawn by GraphPad Prism 6, correlation analysis was by Pearson\'s, survival analysis used Kaplan-Meier survival curve, multivariate analysis of prognostic risk factors of patients adopted Cox regression model. P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

### Comparison of general data

There was no significant difference in sex, age, number of pathological cones, and nerve involvement of patients between the two groups (P\>0.05) ([Table I](#tI-etm-0-0-8310){ref-type="table"}).

### Comparison of time of operation and intraoperative blood loss of patients between the two groups

The time of operation and intraoperative blood loss of patients in the research group were 211.13±31.48 min and 1026.72±316.97 ml, respectively, while the time of operation and intraoperative blood loss of patients in the control group were 302.26±46.75 min and 1603.95±427.51 ml, respectively. The time of operation and intraoperative blood loss of patients in the research group were significantly lower than those in the control group, with statistically significant difference (P\<0.05) ([Fig. 1](#f1-etm-0-0-8310){ref-type="fig"}).

### VAS and KPS scores of patients in the two groups before and after treatment

The VAS and KPS scores of patients in the two groups before treatment were not significantly different (P\>0.05). The VAS scores of patients in the two groups after treatment were lower than those before treatment, and KPS scores were significantly higher than those before treatment. However, the improvement of patients in the research group was more obvious than that in the control group, and the difference was statistically significant (P\<0.05) ([Fig. 2](#f2-etm-0-0-8310){ref-type="fig"}).

### Frankel spinal cord injury grading of patients in the two groups before and after treatment

There was no significant difference in Frankel grading of patients between the two groups before treatment (P\>0.05). Frankel grading of patients in the two groups after treatment was significantly improved compared with that before treatment (P\<0.05). There was no significant difference in Frankel grading after improvement between the two groups (P\>0.05) ([Table II](#tII-etm-0-0-8310){ref-type="table"}).

### Complications of patients in the two groups

The number of patients in the research group with leakage, hemorrhage, deep venous thrombosis of lower limbs, and infection was 2, 1, 1, and 1, respectively, with a complication rate of 7.69%. The number of patients in the control group with leakage, hemorrhage, deep venous thrombosis, and infection was 4, 2, 2, and 3, respectively, with a complication rate of 19.40%. In addition, the complication rate of patients in the research group was significantly lower than that of patients in the control group, with statistically significant difference (P\<0.05) ([Table III](#tIII-etm-0-0-8310){ref-type="table"}).

### Comparison of recurrence rate and survival rate of patients between the two groups

During the 36-month follow-up period, there were no patients who missed the visit. There were 40 patients in the research group who relapsed, with a recurrence rate of 61.54% in 3 years, and 39 patients died, with a 3-year survival rate of 40.00% (26/65). There were 55 patients in the control group who relapsed, with a recurrence rate of 82.09% in 3 years, and 49 patients died, with a 3-year survival rate of 28.36% (19/67). The 3-year recurrence rate of patients in the research group was significantly lower than that in the control group, and the survival rate was significantly higher than that in the control group, with statistically significant difference (P\<0.05) ([Fig. 3](#f3-etm-0-0-8310){ref-type="fig"}).

### Single analysis of poor prognosis in patients with spinal metastasis tumor

We divided patients into death group (88 cases) and survival group (44 cases) according to their 3-year survival conditions. We analyzed the clinical and pathological data of patients in the two groups. The results showed that the number of pathological cones, visceral metastasis, nerve involvement, malignant degree, and radiofrequency ablation treatment may be the factors affecting the poor prognosis of patients (P\<0.05) ([Table IV](#tIV-etm-0-0-8310){ref-type="table"}).

### Multivariate analysis of poor prognosis in patients with spinal metastasis tumor

Through single factor analysis, we found that the number of pathological cones, visceral metastasis, nerve involvement, malignant degree, and radiofrequency ablation therapy might be factors that affect the poor prognosis of patients. Then we assigned values to the single factors that have differences ([Table V](#tV-etm-0-0-8310){ref-type="table"}) and further included the single factors that have differences into Cox risk proportion model for analysis. The results showed that the number of pathological cones, visceral metastasis, malignant degree, and radiofrequency ablation therapy were independent risk factors that affect the poor prognosis of patients. More details are shown in [Table VI](#tVI-etm-0-0-8310){ref-type="table"}.

Discussion
==========

Spine is a high incidence site for malignant tumor metastases. Spinal metastatic tumors will lead to intractable pain and nerve compression and other symptoms, which will have a serious impact on the quality of life of patients ([@b13-etm-0-0-8310]). At present, the treatment of spinal metastases mainly focuses on nerve compression of patients and pain relief. In the past, conservative methods such as radiotherapy, chemotherapy, and palliative treatment were mainly adopted to treat spinal metastases, but the efficacy was not good ([@b14-etm-0-0-8310]). Therefore, it is of great clinical significance to find a treatment method with better efficacy for patients with spinal metastases.

In the present study, we analyzed the clinical efficacy of simple surgery and radiofrequency ablation assisted surgery in the treatment of spinal metastases and the impact on the prognosis of patients. This research was carried out due to the continuous development of surgical techniques in recent years, and surgery has gradually become the main method for the treatment of spinal metastases ([@b15-etm-0-0-8310]). Previous studies ([@b16-etm-0-0-8310]) have shown that surgical treatment can better improve the neurological function of patients with spinal metastases, and it is considered to be superior to radiotherapy and chemotherapy in relieving pain of patients. However, simple cone resection not only has great trauma to the patients, but also leads to a higher recurrence rate for some tumors that are difficult to be excised ([@b17-etm-0-0-8310]). Radiofrequency ablation is a thermal ablation technique gradually applied in tumor treatment in recent years, and friction heat can be generated by alternating current, so as to perform targeted ablation on tumors, which is beneficial to local control of metastatic lesions ([@b18-etm-0-0-8310]). The results of our study show that the time of operation and intraoperative blood loss of patients in the research group are significantly lower than those in the control group, which suggests that we can effectively reduce the time of operation and blood loss when radiofrequency ablation is used to assist surgery.

Previous studies ([@b19-etm-0-0-8310],[@b20-etm-0-0-8310]) have shown that one of the advantages of radiofrequency ablation is that it can coagulate tumor microvessels locally through thermal ablation, which is conducive to reducing the density of blood vessels and the amount of bleeding during surgery, and is also conducive to surgical operation so as to shorten the time of operation, which proves and explains our results. Then the VAS, KPS scores, and Frankel grading of patients in the two groups before and after surgery were compared. The results showed that the VAS, KPS scores, and Frankel grading of patients in the two groups after treatment were significantly improved compared with those before treatment. However, the VAS and KPS scores of patients in the research group were more improved than those in the control group, and there was no significant difference in the improved number of Frankel grading. This suggests that surgery has a good effect on the neurological function recovery of patients with spinal metastases, but if assisted with radiofrequency ablation, it can more effectively relieve pain of patients and promote the functional recovery of patients.

Previous research ([@b18-etm-0-0-8310]) have indicated that when radiofrequency ablation and surgery are combined, radiofrequency ablation can create ablation gaps in the pathological cones, which is conducive to the injection of bone cement and the reduction of leakage rate, thus relieving the pain of patients. In addition, there is also research ([@b21-etm-0-0-8310]) showing that the pain relief rate for patients with spinal metastases can reach 100% when radiofrequency ablation and surgery are combined. This is consistent with our conclusion. The complications and 3-year survival rate of patients in the two groups were compared. The results showed that the incidence rate of complications of patients in the research group was significantly lower than that of the control group, and the 3-year recurrence rate was significantly lower than that of the control group. The 3-year survival rate was significantly higher than that of the control group. This suggests that the application of radiofrequency ablation in the surgical operation of spinal metastases is beneficial to reduce the occurrence of postoperative complications and tumor recurrence and prolong the survival time of the patients. Previous research ([@b22-etm-0-0-8310]) have indicated that radiofrequency ablation can directly act on the tumor itself, and ablation technology can cause coagulation necrosis of the tumor, which can enhance the efficacy of the surgery and reduce recurrence.

For a long time, the prognosis of spinal metastases has been a difficult clinical problem. Although we found in previous studies that the use of radiofrequency ablation may affect the prognosis of patients, it still needs further confirmation in subsequent experiments. Therefore, we analyzed the factors that affected the prognosis of patients with spinal metastases. The results showed that the number of pathological cones, visceral metastasis, malignant degree, and radiofrequency ablation therapy were independent risk factors that affected the prognosis of patients with spinal metastases. Previous studies ([@b23-etm-0-0-8310]) have indicated that the malignant degree of the tumor itself will have a direct impact on the prognosis of patients. There is also research ([@b24-etm-0-0-8310]) that organ metastasis of tumor is an important factor affecting poor prognosis of tumor patients. Moreover, for patients with spinal metastases, a larger number of cones means a greater treatment risk and a longer postoperative recovery time, which will also have an important impact on the prognosis of patients ([@b25-etm-0-0-8310]). However, radiofrequency ablation is proposed for the first time in our study as a protective factor for the prognosis of patients with spinal metastases, which needs further research in the future.

Collectively, radiofrequency ablation assisted surgery can effectively improve the clinical efficacy of patients with spinal metastases, reduce the postoperative complications and recurrence rate of patients, and prolong the survival time of patients compared with simple surgical treatment. Moreover, the malignant degree of tumors, the presence or absence of organ metastasis and the number of pathological cones are independent risk factors leading to poor prognosis of patients. The application of radiofrequency ablation is a protective factor for the prognosis of patients. In our opinion, patients conforming to the principles of surgical treatment should be recommended the use of radiofrequency ablation assisted surgery.
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![Comparison of time of operation and intraoperative blood loss of patients between the two groups. (A) The time of operation of patients in the research group is significantly lower than that of patients in the control group. (B) The intraoperative blood loss of patients in the research group is significantly lower than that of patients in the control group. \*P\<0.05.](etm-19-02-1072-g00){#f1-etm-0-0-8310}
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###### 

General data.

  Factors                        Research group n=65   Control group n=67   t/χ^2^ value   P-value
  ------------------------------ --------------------- -------------------- -------------- ---------
  Sex                                                                       0.131          0.717
    Male                         36 (55.38)            35 (52.24)                          
    Female                       29 (44.61)            32 (47.76)                          
  Age (years)                      56.07±10.11         57.12±9.85           0.547          0.604
  BMI (kg/m^2^)                  22.54±1.48            22.37±1.52           0.651          0.516
  Number of pathological cones                                              0.270          0.966
    1 segment                    36 (55.38)            39 (58.21)                          
    2 segments                   13 (20.22)            14 (20.90)                          
    3 segments                   10 (15.38)              9 (13.43)                         
    4 segments                   6 (9.23)              5 (7.46)                            
  Nerve involvement                                                         0.032          0.858
    Yes                          31 (47.69)            33 (49.25)                          
    No                           34 (52.31)            34 (50.75)                          
  Malignant degree                                                          0.280          0.869
    High                         20 (30.77)            21 (31.34)                          
    Moderate                     30 (46.15)            33 (49.25)                          
    Low                          15 (23.08)            13 (19.40)                          

###### 

Frankel spinal cord injury grading of patients in the two groups before and after treatment.

               Before treatment   After treatment                                                                               
  ------------ ------------------ ----------------- --------- --------- --- --- --------- --------- --------- --------- ------- -------
  Research     0                  10                36        19        0   0   5         27        26        7         11.04   0.012
  group n=65                      (15.38)           (55.38)   (29.23)           (7.69)    (41.54)   (40.00)   (10.77)           
  Control      0                  11                36        20                9         27        25        6         8.041   0.045
  group n=67                      (16.42)           (53.73)   (29.85    0   0   (13.43)   (40.30)   (37.31)   (8.96)            
  χ^2^ value                                        0.043                                 1.209                                 
  P-value                                           0.979                                 0.751                                 

###### 

Complications of patients in the two groups.

  Factors                                 Research group n=65   Control group n=67   χ^2^ value   P-value
  --------------------------------------- --------------------- -------------------- ------------ ---------
  Leakage                                 2 (3.08)              6 (8.96)             2.002        0.157
  Hemorrhage                              1 (1.54)              2 (2.99)             0.311        0.577
  Deep venous thrombosis of lower limbs   1 (1.54)              2 (2.99)             0.311        0.577
  Infection                               0                     3 (4.48)             2.978        0.084
  Total incidence rate                    4 (7.69)              13 (19.40)           5.162        0.023

###### 

Single analysis of poor prognosis in patients with spinal metastasis tumor.

  Factors                           Survival group n=44   Death group n=88   t/χ^2^ value   P-value
  --------------------------------- --------------------- ------------------ -------------- ---------
  Sex                                                                        0.061          0.805
    Male                            21 (47.73)            40 (45.45)                        
    Female                          23 (52.27)            48 (54.55)                        
  Age (years)                       57.15±9.27            56.42±9.68         0.414          0.679
  Number of pathological cones                                               18.71          \<0.001
    1 segment                       36 (81.82)            39 (44.32)                        
    2 segments                      6 (13.64)             21 (23.86)                        
    3 segments                      2 (4.54)              17 (19.32)                        
    4 segments                      0                     11 (12.51)                        
  Visceral metastasis                                                        7.443          0.006
    Yes                             12 (27.27)            46 (52.27)                        
    No                              32 (72.73)            42 (47.73)                        
  Nerve involvement                                                          5.475          0.019
    Yes                             15 (34.09)            49 (55.68)                        
    No                              23 (52.27)            39 (44.32)                        
  Malignant degree                                                           10.74          0.005
    High                              8 (18.18)           33 (37.50)                        
    Moderate                        20 (45.45)            43 (48.86)                        
    Low                             16 (36.36)            12 (13.64)                        
  Radiofrequency ablation therapy                                            11.88          \<0.001
    Yes                             31 (70.45)            34 (38.64)                        
    No                              13 (29.55)            54 (61.36)                        

###### 

Assignments.

  Factors                     Assignment
  --------------------------- -------------------------------------------------------
  No. of pathological cones   1 segment=1, 2 segments=2, 3 segments=3, 4 segments=4
  Visceral metastasis         Not transferred=1, transferred=2
  Malignant degree            Low=1, moderate=2, high=3
  Radiofrequency ablation     Yes=1, no=2
  Nerve involvement           No=1, yes=2
  Living conditions           Survival=1, death=2

###### 

Multivariate analysis of poor prognosis in patients with spinal metastasis tumor.

  Independent variable        β       SE      Wald     P-value   OR      95% CI
  --------------------------- ------- ------- -------- --------- ------- --------------
  No. of pathological cones   1.171   0.482   5.543    0.014     3.229   2.819--7.531
  Visceral metastasis         1.085   0.544   11.176   0.001     6.082   1.085--8.039
  Malignant degree            1.077   0.536   11.168   0.001     6.084   1.076--8.031
  Radiofrequency ablation     1.238   0.455   7.208    0.004     3.452   2.117--7.307
  Nerve involvement           0.927   1.169   0.624    0.472     --      --
